Form 4 Tracker
Michael Severino

Director; Director, Chief Executive Officer · 3 filings · Latest: Jul 28, 2026

Avantor, Inc.
Sarepta Therapeutics, Inc.
Viatris Inc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
VTRS
Michael SeverinoDirectorMar 6, 2026
Option Exercise
$0.0026,03126,031